Lead global regulatory strategies for Olema Oncology's products, focusing on innovative therapies for breast cancer.
Posted by employer 1 day ago
First seen on Joblaze 4 hours ago
Last verified on the company career page 4 hours ago
What you'll build
Must have
Nice to have
Practical constraints
Requirements
Not disclosed in this posting: visa sponsorship.
Joblaze summary
The Director of Global Regulatory Affairs at Olema Oncology is responsible for crafting and executing regulatory strategies that support the company's clinical products, particularly in oncology. This role requires expertise in regulatory submissions and strong negotiation skills with health authorities, as well as a solid background in the pharmaceutical or biotech sectors, ideally with oncology experience. The position suits seasoned professionals with at least 12 years in regulatory affairs and a proactive approach to managing multiple projects. Olema's small, agile team emphasizes collaboration and adaptability in a fast-paced environment.
Joblaze insights
Quick facts
From the original posting
Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. With our transformation into a fully integrated oncology company well underway, it’s an exciting time to be part of Team Olema.
Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in Q1 2027 which, if positive, could lead to our first potential approval and commercial launch in 2028. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant could transform the metastatic breast cancer treatment paradigm and provide access to a $15 billion global market opportunity.
Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently presented encouraging Phase 1 monotherapy data from this program across multiple solid tumor types, are advancing patient enrollment in the ongoing combination arms in MBC, and expect to initiate a Phase 1 study of OP-3136 in combination with Bayer’s darolutamide in metastatic castration-resistant prostate cancer by the end of this year.
Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and passionate colleagues dedicated to helping the patients we serve feel better, longer. Team Olema possesses a deep commitment to a shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, the drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. We are a small group of nimble self-starters who bring consistency in our quest for the extraordinary every single day.
If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.
About the Role
As the Director, Global Regulatory Strategy Lead - Regulatory Affairs reporting to the Senior Director of Regulatory Affairs, you will lead the development and execution of innovative regulatory strategies supporting Olema products. You will also represent Regulatory Affairs on cross-functional teams as the subject matter expert and provide regulatory guidance and oversight to the global project teams, Study Execution Teams, and the Executive Committee. You will provide strategic and tactical guidance and lead the development of regulatory submissions (INDs, CTx, briefing documents, IB, NDA, BLA, DMF, IMPD etc.)
This role is based out of our Boston, MA or San Francisco, CA office and will require domestic and international travel up to 20%.
Your work will primarily encompass:
And will also include the following:
Ideal Candidate Profile >>> Innovative Experienced Regulatory Strategy Leader
Knowledge:
Experience:
Attributes:
The base pay range for this position is expected to be $230,000 - $250,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.
#LI-MK1
Important Information >>>
Standard company text repeated across Olema Oncology's postings is omitted here.